Kalaris Therapeutics Inc
USD4.72
+0.07 (+1.51%)
CEO
Andrew Oxtoby
IPO Date
2020-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.66
Prev. Close
$4.65
Day Low
$4.66
Day High
$4.97
52W Low
$2.14
52W High
$11.88
Market Cap
$0.09B
Volume
0.05M
| 66,906 |
| $0.00 |
| 22 May 2026 | AKKARAJU SRINIVAS | director, 10 percent owner: | J-Other | Acquired | 14,937 | $0.00 |
| 22 May 2026 | AKKARAJU SRINIVAS | director, 10 percent owner: | J-Other | Acquired | 4,471 | $0.00 |
| 23 Mar 2026 | Hagen Brett R | Chief Accounting Officer | S-Sale | Disposed | 1,915 | $6.72 |
| 23 Mar 2026 | Hagen Brett R | Chief Accounting Officer | A-Award | Acquired | 60,800 | $6.81 |
| 20 Mar 2026 | Oxtoby Andrew | director, officer: See Remarks | A-Award | Acquired | 222,000 | $6.81 |
| 20 Mar 2026 | Gall Matthew | Chief Financial Officer | A-Award | Acquired | 95,000 | $6.81 |
| 20 Mar 2026 | Feinsod Matthew | Chief Medical Officer | A-Award | Acquired | 135,000 | $6.81 |
| 17 Feb 2026 | AKKARAJU SRINIVAS | director, 10 percent owner: | P-Purchase | Acquired | 479,847 | $10.42 |